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Ductal carcinoma in-situ (DCIS) is a noninvasive malignancy and a 
potential precursor to invasive cancer 
at pathologic analysis, DCIS shows 
proliferation of malignant epithelial 
cells that line the ducts (at the level 
of the terminal ductal–lobular unit) 
(Fig 1) without invasion through the 
basement membrane The detection 
rate of DCIS has increased markedly 
over the past two decades with the 
advent of breast cancer screening. 
Early detection and assessment 
of extent of DCIS is important for 
planning successful conservative 
breast surgery. Half the cases of 
recurrent DCIS are associated with 
invasive ductal cancer. In addition, 
20% of patients with DCIS develop 
metastases within 10 years of initial 
diagnosis. 
In the following article, we will 
review the findings of DCIS on 
mammography and breast ultrasound 
(US) and also discuss the role of 
breast Magnetic Resonance Imaging 
(MRI) for improved detection of DCIS. 
Over 90% of cases of DCIS are 
detected as microcalcifications on 
mammography. These calcifications 
are calcified cellular debris or 
secretions within the intraductal 
lumen. The uneven calcification 
of the cellular debris explains the 
fragmentation and irregular contours 
of the calcifications.
Figure 2 shows the distinction 
between linear and rounded 
microcalcifications that helps 
distiguish acinar (mostly benign) from 
ductal (suspicious for malignancy)-
type calcifications. Calcifications are 
extremely variable in size, density 
and form; they may be amorphous 
(morphus means form in Greek, 
amorphus means no particular form), 
pleomorphic (pleo is Greek for more 
or many forms), heterogeneous (mixed 
density), rounded, coarse (≥5mm) or 
fine (<5mm). Their distribution may 
be clustered, linear, or segmental 
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(Fig 3). The diagnostic approach to 
breast calcifications is to analyze 
the morphology, distribution and 
sometimes change over time.
Pleomorphic calcifications 
distributed in a linear fashion or 
in a cluster (>5 calcifications in an 
area of 1cm diameter) should raise 
enough suspicion to advise biopsy 
(Fig 4). The presence of amorphous 
(Fig 5) or rounded calcifications in 
a linear or clustered distribution 
may also lead to biopsy, however 
the level of suspicion is lower in 
these instances. Dispersed or regional 
distribution of calcifications in one 
or both breasts or in multiple foci is 
usually indicative of benign disease 
(Fig 6). A segmental distribution of 
calcifications especially in the absence 
of pleomorphism is of indeterminate 
significance; in such situations or when 
calcifications are scanty in number, a 
close mammographic follow-up may 
be justified (Fig 7). Fine linear and 
branching calcifications, particularly 
when fragmented, require biopsy  
(Fig 8).   
figure 1. Terminal lobular ductal unit (highlighted) includes the terminal duct with 
extralobular (**) and intralobular (*) portions and the acini.
figure 2. Calcifications may be classified as acinar (round or cresentic) or ductal 
(elongated, linear distribution). 
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figure 7. Mammographic follow-up of scanty calcifications; an increase in 
number of microcalcifications noted after 6 months should herald a biopsy. 
figure 8. Mammogram showing fine linear, branching and fragmented 
calcifications that are strongly indicative of malignant disease and required biopsy. 
figure 5. Mammogram showing amorphous 
calcifications in a clustered distribution. 
figure 4. Mammogram showing pleomorphic 
calcifications in a linear distribution. 
figure 6. Mammogram showing dispersed calcifications. 
figure 3. Distribution of calcifications may be diffuse, regional, segmental or clustered/linear.
to be continued
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